S.-A. Im

934 total citations
39 papers, 686 citations indexed

About

S.-A. Im is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Periodontics. According to data from OpenAlex, S.-A. Im has authored 39 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Periodontics. Recurrent topics in S.-A. Im's work include Advanced Breast Cancer Therapies (8 papers), Oral microbiology and periodontitis research (7 papers) and HER2/EGFR in Cancer Research (7 papers). S.-A. Im is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Oral microbiology and periodontitis research (7 papers) and HER2/EGFR in Cancer Research (7 papers). S.-A. Im collaborates with scholars based in South Korea, United States and Japan. S.-A. Im's co-authors include Do‐Youn Oh, Yung‐Jue Bang, Howard A. Burris, Todd M. Bauer, Paul A. Moore, Giuseppe Giaccone, Jeffrey L. Nordstrom, Samantha Stewart, Robert J. Lechleider and Gurunadh R. Chichili and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal Of Clinical Periodontology.

In The Last Decade

S.-A. Im

37 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.-A. Im South Korea	12	478	271	167	159	93	39	686
Tommasina Biscotti Italy	13	430 0.9×	233 0.9×	38 0.2×	208 1.3×	182 2.0×	21	690
G. Thomas Budd United States	14	451 0.9×	270 1.0×	104 0.6×	136 0.9×	171 1.8×	39	716
Y. Ko Germany	6	221 0.5×	185 0.7×	112 0.7×	67 0.4×	117 1.3×	13	490
Maria D. Begnami Brazil	11	280 0.6×	218 0.8×	56 0.3×	73 0.5×	179 1.9×	22	560
Armando Orlandi Italy	17	519 1.1×	248 0.9×	100 0.6×	248 1.6×	192 2.1×	90	879
Noreli Franco United States	15	199 0.4×	238 0.9×	83 0.5×	183 1.2×	624 6.7×	31	1.1k
Samanta Sarti Italy	17	490 1.0×	193 0.7×	88 0.5×	209 1.3×	205 2.2×	46	803
Kanchan Puttaswamy United States	7	264 0.6×	94 0.3×	32 0.2×	69 0.4×	197 2.1×	10	718
Esther Holgado Spain	15	757 1.6×	367 1.4×	57 0.3×	169 1.1×	129 1.4×	42	870

Countries citing papers authored by S.-A. Im

Since Specialization

Citations

This map shows the geographic impact of S.-A. Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.-A. Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.-A. Im more than expected).

Fields of papers citing papers by S.-A. Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.-A. Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.-A. Im. The network helps show where S.-A. Im may publish in the future.

Co-authorship network of co-authors of S.-A. Im

This figure shows the co-authorship network connecting the top 25 collaborators of S.-A. Im. A scholar is included among the top collaborators of S.-A. Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.-A. Im. S.-A. Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barrios, Carlos H., et al.. (2025). P001: Prognostic variables for risk of recurrence in patients (pts) with HR+/HER2–early breast cancer (EBC) using data from the NATALEE trial: a machine learning (ML) model–based analysis. The Breast. 80. 103895–103895.

Im, S.-A., et al.. (2024). Automated system of scaffold point cloud data acquisition using a robot dog. Automation in Construction. 170. 105944–105944. 1 indexed citations

Im, S.-A., Kyung Hae Jung, Joohyuk Sohn, et al.. (2021). Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11). ESMO Open. 6(5). 100236–100236. 2 indexed citations

Im, S.-A., et al.. (2020). Inhibitory effect of mastic oil on Streptococcus mutans growth. Journal of Korean Academy of Oral Health. 44(4). 175–179. 2 indexed citations

Cristofanilli, Massimo, Dennis J. Slamon, Jungsil Ro, et al.. (2018). Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Analyses from PALOMA-3. Annals of Oncology. 29. viii708–viii708. 6 indexed citations

Choi, Youn‐Hee, et al.. (2017). The brain activation pattern of the medial temporal lobe during chewing gum: a functional MRI study. Neural Regeneration Research. 12(5). 812–812. 9 indexed citations

Bang, Yung‐Jue, Giuseppe Giaccone, S.-A. Im, et al.. (2017). First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors. Annals of Oncology. 28(4). 855–861. 179 indexed citations

Kim, Eun‐Kyong, Sang Gyu Lee, Seong‐Hwa Jeong, et al.. (2016). Dental amalgam exposure can elevate urinary mercury concentrations in children. International Dental Journal. 66(3). 136–143. 4 indexed citations

Finn, RS, Yuqiu Jiang, Hope S. Rugo, et al.. (2016). Biomarker analyses from the phase 3 PALOMA-2 trial of palbociclib (P) with letrozole (L) compared with placebo (PLB) plus L in postmenopausal women with ER + /HER2– advanced breast cancer (ABC). Annals of Oncology. 27. vi554–vi554. 46 indexed citations

10.

Bang, Y-J., Narikazu Boku, Kyung-Woo Lee, et al.. (2016). gastrointestinal tumours, non-colorectal Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy: Phase III GOLD study. Annals of Oncology. 27. vi562–vi562. 9 indexed citations

11.

Im, S.-A., Hirofumi Mukai, Norikazu Masuda, et al.. (2016). 116O Palbociclib (PAL) plus letrozole (L) as first-line (1L) therapy (tx) in postmenopausal Asian women with estrogen receptor-positive (ER +)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (mBC). Annals of Oncology. 27. ix35–ix35. 5 indexed citations

12.

Bae, Kwang‐Hak, Jin‐Bom Kim, Seong‐Hwa Jeong, et al.. (2014). Validity and reliability of a questionnaire for evaluating periodontal disease. Journal of Korean Academy of Oral Health. 38(3). 170–170. 5 indexed citations

13.

Kim, Hye Ryun, Kyung Hae Jung, S.-A. Im, et al.. (2013). Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). Annals of Oncology. 24(6). 1485–1490. 28 indexed citations

14.

Kim, Eun‐Kyong, et al.. (2013). Impact of amalgam removal on urinary mercury concentration in children: a pilot study. Journal of Korean Academy of Oral Health. 37(4). 194–194. 1 indexed citations

15.

Chang, Hye Jung, Sae‐Won Han, Do‐Youn Oh, et al.. (2011). Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab. Japanese Journal of Clinical Oncology. 41(5). 593–599. 46 indexed citations

16.

Lee, Kuhn‐Uk, et al.. (2009). Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma. Annals of Oncology. 20(8). 1402–1407. 49 indexed citations

17.

Moon, Hyeong‐Gon, Wonshik Han, Joon Woo Lee, et al.. (2009). Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment. Annals of Oncology. 20(4). 636–641. 48 indexed citations

18.

Kim, Beom Seok, Dong Wook Kim, S.-A. Im, et al.. (2008). Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Annals of Oncology. 20(1). 121–128. 37 indexed citations

19.

Kim, Kyung Hwa, Eui Kyu Chie, Jin‐Young Jang, et al.. (2008). Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer. Japanese Journal of Clinical Oncology. 39(2). 111–115. 5 indexed citations

20.

Han, Sae‐Won, T. Y. Kim, Keonuk Lee, et al.. (2006). EGFR mutation and intron 1 CA repeat polymorphism as predictive markers of gefitinib responsiveness in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7173–7173. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact